FDA approves fast acting nasal spray related to ketamine for patients with severe depression

about 5 years in Chicago Tribune

A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. The nasal spray from Johnson & Johnson is a chemical cousin...

Mentioned in this news
Share it on